This guideline covers the diagnosis and management of type 1 and type 2 diabetes in children and young people aged under 18. The guideline recommends how to support children and young people and their families and carers to maintain tight control of blood glucose to reduce the long-term risks associated ...
Evidence-based recommendations on semaglutide (Wegovy) for managing overweight and obesity in adults.
Commercial availability
The Wegovy brand of semaglutide is not commercially available yet....
This guideline covers care and treatment for adults (aged 18 and over) with type 1 diabetes. It includes advice on diagnosis, education and support, blood glucose management, cardiovascular risk, and identifying and managing long-term complications.
In June 2022, we reviewed the evidence and made new re...
This guideline covers care and management for adults (aged 18 and over) with type 2 diabetes. It focuses on patient education, dietary advice, managing cardiovascular risk, managing blood glucose levels, and identifying and managing long-term complications.
In June 2022, we reviewed the evidence and mad...
This guideline covers care and management for adults (aged 18 and over) with type 2 diabetes. It
focuses on patient education, dietary advice, managing cardiovascular risk, managing blood glucose
levels, and identifying and managing long-term complications....
The previous treatment guide for type 2 diabetes was prepared by the Estonian Society of Endocrinology
led in 2016 and discussed type 2 diabetes screening, diagnosis and
pharmacological treatment (1). The guideline was prepared as an expert opinion/consensus and no
followed the agreed methodology, which ...
A clinical summary of this KDP was published in the Journal of the Ministry of Health of the Czech Republic .
Diabetes mellitus is a heterogeneous group of diseases whose uniform laboratory manifestation is hyperglycemia. In 2017, the number of diabetics in the Czech Republic was 995,613, of which 762,...
This guideline covers care and treatment for adults (aged 18 and over) with type 1 diabetes....
This guideline covers the diagnosis and management of type 1 and type 2 diabetes in children and young people aged under 18. The guideline recommends how to support children and young people and their families and carers to maintain tight control of blood glucose to reduce the long-term risks associated ...
Diabetes is a chronic, progressive disease characterized by elevated blood glucose levels. Diabetes can lead to complications such as cardiovascular disease, damage to eyes, kidneys and nerves, and premature death. Globally, more than 400 million adults live with diabetes, and diabetes directly caused 1....
